Log in
Enquire now
ALung Technologies

ALung Technologies

A medical device company for patients with respiratory failure. Developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation.

OverviewStructured DataIssuesContributors

Contents

alung.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Respiratory care
Respiratory care
‌
Respiratory dialysis
0
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Internal medicine
Internal medicine
...
Location
Pittsburgh
Pittsburgh
0
B2X
B2B
B2B
CEO
‌
Peter M. DeComo
AngelList URL
angel.co/alung-technologies
Number of Employees (Ranges)
1,001 – 5,0000
Email Address
service@alung.com0
Phone Number
+141269733700
Full Address
2500 Jane St Ste 1, Pittsburgh, PA 15203, US0
Investors
Riverfront Ventures
Riverfront Ventures
Innovation Works
Innovation Works
0
West Capital Advisors
West Capital Advisors
0
BlueTree Allied Angels
BlueTree Allied Angels
0
Accelerator Fund
Accelerator Fund
0
Philips
Philips
Eagle Ventures
Eagle Ventures
0
Birchmere Ventures
Birchmere Ventures
...
Founded Date
1997
Total Funding Amount (USD)
60,000,000
Latest Funding Round Date
April 11, 2017
Glassdoor ID
661683
Latest Funding Type
Series C
Series C
Wellfound ID
alung-technologies
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
36,000,000

ALung Technologies is an advanced medical device company for treating respiratory failure. The company is developing the Hemolung Respiratory Assist System (RAS), a dialysis-like alternative or supplement to mechanical ventilation. The Hemolung RAS provides Respiratory Dialysis, a less invasive form of extracorporeal CO2 removal. By removing carbon dioxide and delivering oxygen directly to the blood, the Hemolung RAS allows the patient’s lungs to rest and heal. Applications of the device include preventing intubation in acute exacerbation of chronic obstructive pulmonary disease (COPD) and enabling ultra-protective ventilation in acute respiratory distress syndrome (ARDS).

ALung’s Hemolung RAS was originally developed at the University of Pittsburgh. The device is limited by United States law to investigational use. ALung is conducting a pivotal investigational device exemption trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbations of chronic obstructive pulmonary disease (COPD). The VENT-AVOID Trial is the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.

The company was founded in 1997 and is based in Pittsburgh, Pennsylvania.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like ALung Technologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.